Cell Line : SK-N-MC
Cellosaurus Index : CVCL_0530
Cellosaurus ID : SK-N-MC
CTRP2 Name
: SKNMC
CCLE Name
: SKNMC_BONE
Cancer Type : bone
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| SK-N-MC | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 17.0000 |
|
| SK-N-MC | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-MC | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| SK-N-MC | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | AZD8055 | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | bardoxolone methyl | CTRP2 | 0.0041 | 66.0000 |
|
| SK-N-MC | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| SK-N-MC | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| SK-N-MC | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K24690302 | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| SK-N-MC | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| SK-N-MC | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| SK-N-MC | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K55116708 | CTRP2 | 0.0020 | 17.0000 |
|
| SK-N-MC | BRD-K55473186 | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| SK-N-MC | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| SK-N-MC | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | BRD4132 | CTRP2 | 0.0049 | 80.0000 |
|
| SK-N-MC | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD8899 | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | canertinib | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| SK-N-MC | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| SK-N-MC | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| SK-N-MC | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| SK-N-MC | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| SK-N-MC | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-MC | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-MC | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| SK-N-MC | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| SK-N-MC | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| SK-N-MC | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| SK-N-MC | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | FQI-2 | CTRP2 | 0.0010 | 17.0000 |
|
| SK-N-MC | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| SK-N-MC | GANT-61 | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| SK-N-MC | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| SK-N-MC | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-MC | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-MC | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| SK-N-MC | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-MC | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| SK-N-MC | marinopyrrole A | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | MG-132 | CTRP2 | 0.0006 | 20.0000 |
|
| SK-N-MC | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | MIRA-1 | CTRP2 | 0.0020 | 17.0000 |
|
| SK-N-MC | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-MC | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| SK-N-MC | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| SK-N-MC | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-MC | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-MC | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| SK-N-MC | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-MC | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-MC | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| SK-N-MC | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| SK-N-MC | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| SK-N-MC | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| SK-N-MC | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| SK-N-MC | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | pluripotin | CTRP2 | 0.0010 | 17.0000 |
|
| SK-N-MC | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-MC | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| SK-N-MC | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| SK-N-MC | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| SK-N-MC | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| SK-N-MC | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-MC | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-MC | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-MC | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-MC | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-MC | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-MC | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-MC | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| SK-N-MC | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-MC | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-MC | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| SK-N-MC | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| SK-N-MC | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-MC | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-MC | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-MC | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-MC | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| SK-N-MC | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| SK-N-MC | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-MC | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Tivozanib | CTRP2 | 0.0004 | 13.0000 |
|
| SK-N-MC | Topotecan | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-MC | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| SK-N-MC | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| SK-N-MC | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| SK-N-MC | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| SK-N-MC | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| SK-N-MC | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| SK-N-MC | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-MC | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-MC | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-MC | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-MC | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-MC | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| SK-N-MC | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC